SIX:CMHC

Cosmo N.V. · SIX · Healthcare · CHF · FY for 2025

Figures on this page computed 2026-11-08 12:57 UTC

Last close

n/aCHF

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CHF
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-3.5%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
-15.1%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CHF
- Computed from the filing for 2025
- Computed from the filing for 2025
3.3%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CHF
- computed

Growth is the furthest below its sector's middle: 0.36 against 0.50 on the market's range.

All from 100

lens 2 of 9

Sales

154

2016-12-31 to 2025-12-31100 at the start154

Sales: 100.00 on 2016-12-31 to 153.96 on 2025-12-31, up 54%.

Profit

-18.7

2016-12-31 to 2025-12-31100 at the start-18.7

Profit: 100.00 on 2016-12-31 to -18.66 on 2025-12-31, down 119%.

Shares in issue

111

2016-12-31 to 2025-12-31100 at the start111

Shares in issue: 100.00 on 2016-12-31 to 110.88 on 2025-12-31, up 11%.

Sales is at 154, Profit is at -19, Shares in issue is at 111, against 100 in 2016.

Sales is at 154, Profit is at -19, Shares in issue is at 111, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100154
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Profit, where the first year is 100-19
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Shares in issue, where the first year is 100111
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR